Publications by authors named "Yuka Morikawa-Inomata"

Claim this Profile
P
Pharmacodynamic and pharmacokinetic evaluation of CS-526 in cynomolgus monkeys.
Keiichi Ito, Kazuya Kinoshita, Naotoshi Yamamura, Atsuyuki Tomizawa, Fumi Inaba, Yuka Morikawa-Inomata

Biol Pharm Bull· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of subchronic administration of 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methylcyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526), a novel acid pump antagonist, on gastric acid secretion and gastrin levels in rats.
Keiichi Ito, Kazuya Kinoshita, Atsuyuki Tomizawa, Yuka Morikawa-Inomata, Fumi Inaba

J Pharmacol Exp Ther· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
Keiichi Ito, Kazuya Kinoshita, Atsuyuki Tomizawa, Fumi Inaba, Yuka Morikawa-Inomata

J Pharmacol Exp Ther· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis